tbuckley/cabot-search huggingface dataset:
Epidemic measles in a divided city
Authors: P. J. Landrigan
Journal: JAMA (1972)

Between June 1970 and January 1971, 633 cases of measles occurred in Texarkana, a city bisected by the Texas-Arkansas state line. A total of 606 (95.7%) of the cases occurred in Texarkana (Bowie County), Tex, a community that had never had a measles vaccination campaign. The level of prior immunity, natural plus vaccine-induced, in the 11,185 children aged 1 to 9 years in Bowie County was estimated to be 57%. Only 27 cases occurred in Texarkana (Miller County), Ark, where more than 95% of the 6,016 children aged 1 to 9 years were immune. Nineteen of the 27 Arkansas patients had documented exposures in Texas. Twenty-seven cases of measles occurred in previously vaccinated children. Six of these children had received vaccine with measles immune globulin prior to 1 year of age. Vaccine efficacy was calculated to be 95.9%.
Leukemia in the Proximity of a German Boiling-Water Nuclear Reactor: Evidence of Population Exposure by Chromosome Studies and Environmental Radioactivity
Authors: Inge Schmitz-Feuerhake, Bettina Dannheim, Anna Heimers, Boris Oberheitmann, Heike Schroder, Heiko Ziggel
Journal: Environmental Health Perspectives (1997)

Exceptional elevation of children's leukemia appearing 5 years after the 1983 startup of the Krimmel nuclear power plant, accompanied by a significant increase of adult leukemia cases, led to investigations of radiation exposures of the population living near the plant.The rate of dicentric chromosomes in peripheral blood lymphocytes of seven parents of children with leukemia and in 14 other inhabitants near the plant was significantly elevated and indicated ongoing exposures over the years of its operation.These findings led to the hypothesis that chronic reactor leakages had occurred.This assumption is supported by identification of artificial radioactivity in air, rainwater, soil, and vegetation by the environmental monitoring program at the nuclear power plant.Calculations of the corresponding source terms show that emissions must have been well above authorized annual limits.Bone marrow doses supposedly result primarily through incorporation of bone-seeking ,and a-emitters.
Instructions to Authors
Journal: Cardiovascular Research (2006)

It should be structured into the subsections 'Objective', 'Methods', 'Results' and 'Conclusion(s)'.Give the name of the animal species, if applicable, in the subsection 'Methods'.(3) Keywords.These will be published with your article.During online submission, they are typed into a window.A maximum of 5 keywords is required for publication of the
P-187 Impact on survival of local complications in pancreatic cancer: Experience at the Ramón y Cajal University Hospital (HURyC)
Authors: M. Gil, D. Rosero Rodríguez, E. Corral de la Fuente, R. Martín Huertas, L. Sanz, J. Pozas, P. Ballesteros, V. Albarrán Fernandez, J. Chamorro Perez, M. Vaz, M. Villamayor Delgado, R. Fuentes, V. Pachón Olmos, P. Reguera Puertas, M. Rodriguez Garrote, R. Ferreiro Monteagudo, A. Carrato, F. Longo, J. Serrano Domingo
Journal: Annals of Oncology (2020)
Magazine, Radio and TV Report
Journal: JAMA (1967)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Easy access to emergency contraception does not make it the contraceptive of choice
Journal: BMJ (1999)

Treatment for athlete's foot should begin with over the counter drugs On p 79 Hart et al report the first systematic review of topical antifungal drugs for athlete's foot.Allylamines, available only on prescription, cure slightly more fungal infections of the skin of the feet than azoles and undecenoic acid, both of which are available over the counter.The comparatively high cost of allylamines, however, means that the few extra cures are expensive.So it is best to begin treatment with an azole or undecenoic acid, and to reserve allylamines for those infections that do not respond.
Errors in Course Listings
Journal: JAMA (1975)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Jet Injectors
Authors: Michael Golden, Morey Haymond, Deborah Hin- Nen, Davida Kruger, O Schumacher
Journal: Diabetes Care (1991)

Jet InjectorsJ et injection was first proposed for administering insulin over 35 yr ago (1).The stated rationale for the initial devices was to decrease pain of injection compared with needles and syringes (2).There was little further application of jet injection to the treatment of diabetes for over 10 yr, although jet injection developed wide use for mass immunization programs.Recently, the application of jet injection to administering insulin has gained increasing attention.Marketing campaigns by private industry have noticeably increased.The Task Force on Jet Injection of the Youth Council of ADA was formed to review the scientific literature available on jet injectors and, if possible, to recommend guidelines for their use.The available scientific literature is not sufficient to provide recommendations for the general use of these devices.However, sufficient data are available to support the following specific conclusions.First, jet injection of insulin appears to offer a mechanically reliable and accurate alternative to syringe injection; however, the comparable precision and accuracy of insulin delivery, reliability, safety, and patient acceptability of all available devices when compared with syringe injection need to be assessed by disinterested investigators and the results published in the medical literature (3).Based on results of testing with one model, jet injection does not appear to be associated with increased risk for infection (4), although again each model needs to be individually evaluated.Second, insulin absorption and distribution differ when insulin is administered by jet injection from when sy-
Abstract 2344: Cumulative Radiation Dose Estimate From Medical Testing in Grown-Up Patients With Congenital Heart Disease
Authors: Lamia Ait-Ali, Nicoletta Botto, Maria Grazia Andreassi, Pierluigi Festa, Eugenio Picano
Journal: Circulation (2007)

Background: The “Biological effects of Ionizing Radiation” (BEIR VII,2005) underlines “the need of studies of infants who are exposed to diagnostic radiation”. Aim: to assess the individual cumulative lifetime radiological dose in grown up congenital heart disease (GUCH) patients. Methods: In 41 consecutive operated GUCH patient (24 males, age= 27 ± 9 years old), followed in our outpatient clinic, a cumulative radiological history was collected with a structured questionnaire and access to lifetime hospital records. All patient underwent at least one surgical intervention during the infancy for Tetralogy of Fallot (n=18), aortic coarctation (n=10), anatomical/functional univentricular heart (n=8), other congenital heart disease (n=5) The cumulative exposure was expressed in milliSievert (mSv) and derived from average effective dose estimates of individual examinations proposed by the European Commission Medical Imaging Guidelines (2001). The attributable cancer risk was estimated from BEIR VII, 2005 document. Results: On average, cumulative dose estimate was 22.3 ± 12.4 (mean ± SD) mSv per patient, equivalent to about 1115 ± 620 chest x-rays. Diagnostic and interventional catheterization accounted for the most important sources of exposure (see figure ). The median cumulative dose gave an average extra-risk of cancer of about 1 out of 200 patients (range, 1 in 448 to 1 out of 58). Conclusion: the average contemporary GUCH patient is exposed to a significant cumulative radiological effective dose. Every effort should be done to justify the indications and to optimise dose delivery during ionizing testing.
Lehrbuch der Kinderheilkunde für Aerzte und Studierende.
Journal: JAMA (1924)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
PSROs and Norms of Care
Journal: JAMA (1974)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
JAMA Reference Directories
Journal: JAMA (1986)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
PSYCHIC THERAPEUTICS.
Authors: J. C. CULBERTSON
Journal: JAMA (1901)

A dictionary definition of this term says, it is "a systematic use of personal influence, especially that of the physician, in treatment of nervous diseases." In this definition may be found a good and sufficient reason for the success of some practitioners of medicine and apparently unaccountable failure of others. Nor is failure or success attributable to the specific materia medica remedies made use of by the physician in attendance upon the sick. The influence of the mind over the body in conditions of health as well as of disease is always paramount. In a consideration of this influence, it is desirable that we remember the prime subdivisions indicated by the will, intellect and emotions. Together, these constitute and are the faculties of the mind. In health they are in a state of equilibrium. In sickness the balance is disturbed. The will becomes weakened, as shown by an increased pliability
Error in Data Presentation in Text and Table
Journal: JAMA (2018)

Amol S. Navathe, MD, PhD; Joshua M. Liao, MD, MSc; Sarah E. Dykstra, BA; Erkuan Wang, MA; Zoe M. Lyon, BA; Yash Shah, BA; Joseph Martinez, BA; Dylan S. Small, PhD; Rachel M. Werner, MD, PhD; Claire Dinh, BA; Xinshuo Ma, MS; Ezekiel J. Emanuel, MD, PhD
Evaluation of the health hazard of clove cigarettes. Council on Scientific Affairs
Journal: JAMA (1988)

Resolution 43 (1987 Annual Meeting), adopted by the House of Delegates, resolved that the American Medical Association study the dangers associated with clove cigarettes, that policy recommendations regarding regulation of clove and other tobacco additives be developed, and that this information be made available to physicians and the public. Clove cigarettes are tobacco products. They therefore possess all the hazards associated with smoking all-tobacco cigarettes. In addition, inhaling clove cigarette smoke has been associated with severe lung injury in a few susceptible individuals with prodromal respiratory infection. Some individuals with normal respiratory tracts have apparently suffered aspiration pneumonitis as the result of a diminished gag reflex induced by a local anesthetic action of eugenol (the active component of cloves), which is volatilized into the smoke. The American Medical Association has an existing policy vigorously opposing the use of any tobacco product; no exemption from this policy is made for clove-containing cigarettes.
Onychectomy
Authors: Robert B. Rakow
Journal: JAMA (1969)

<h3>To the Editor:—</h3> Only the lateral or medial 25% (offending portion) of the nail plate and its underlying bed and matrix need be resected.... By careful dissection the surgeon can remove the bed and matrix in toto, proceeding from the distal end of the toe and working proximally. Techniques to close the operative site allow the skin margins to lie adjacent and below the 75% of the nail plate left intact....
Ugeskrift for Laeger, Copenhagen
Journal: JAMA (1966)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
LITERATURE REFERENCES.
Journal: JAMA (1902)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
CD56 and terminal deoxynucleotidyl transferase positive cutaneous lymphoblastic lymphoma
Authors: Y. Amo, K. Yonemoto, T. Ohkawa, M. Sasaki, Y. Isobe, K. Sugimoto, K. Katsuoka
Journal: British Journal of Dermatology (2000)

Sir, Recently, lymphoblastic lymphomas of putatively immature or progenitor natural killer (NK)‐cell lineage have been reported.1–4 These lymphomas possess particular characteristic features, including positivity for CD56 and terminal deoxynucleotidyl transferase (TdT), negativity for Epstein–Barr virus (EBV), and no rearrangements of T and B cell immunoassociated genes.2–4 This report provides a description of a rare case of lymphoblastic lymphoma expressing an NK cell phenotype and with initial expression in the skin. A 39‐year‐old Japanese man was referred to our hospital in September 1998, complaining of multiple, indurated, slightly reddish plaques up to the size of a thumb‐tip; the plaques were located on his left cheek, forearms and trunk (Fig. 1a). The patient first became aware of a plaque on his left forearm in April 1996. Further lesions developed on his left cheek, right forearm and trunk during March 1998. A biopsy specimen obtained from the nodule on his back revealed diffuse proliferation of neoplastic cells, which were medium‐sized and had irregularly folded delicate nuclear membranes, fine chromatin, and tiny nucleoli (Fig. 1b). Angiocentric features were not seen in the biopsy section. The majority of lymphocytes were positive for TdT and CD56, but negative for CD2, CD3, CD4, CD5, CD8, CD16, CD20, CD25, CD30, CD34, CD45RO, CD57 and myeloperoxidase (MPO). The neoplastic cells were negative for EBV‐encoded latent membrane protein‐1 by immunohistochemistry, and negative for EBV‐encoded small RNAs by in situ hybridization. Immunogenotyping showed germline configurations for the T‐cell receptor Cβ1 gene and T‐cell receptor Jγ gene chain constant regions and the immunoglobulin heavy‐chain gene in the skin specimen. A PCR assay was performed to detect the EBV genome, and Southern blotting analysis was performed to test for the EBV terminal repeat; both tests were negative in the skin specimen. In addition, transmission electron microscopy revealed a few membrane‐bound electron‐dense granules measuring 200–500 nm in diameter in the cell cytoplasm.
Comments and Critiques on the EMBRACE Health Care Reform Plan
Authors: Christopher K. Johnson
Journal: Annals of Internal Medicine (2009)

Letters3 November 2009Comments and Critiques on the EMBRACE Health Care Reform PlanChristopher K. Johnson, MDChristopher K. Johnson, MDFrom University of Washington, Seattle, WA 98104.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-151-9-200911030-00018 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail TO THE EDITOR:I appreciated the lucid and coherent alternative health care proposal from Lancaster and colleagues (1). After studying the Oregon rationing experiment and the current system, as well as single-payer alternatives, I concluded that a multitiered system made the most sense. Now I have a specific plan to embrace. We should cover basic care for everyone, but we cannot cover all care for all persons at all times. Rationing rationally, while leaving in place market forces to encourage dynamism and progress in new therapies, combines the best of both models. One could argue that we already have a ...Reference1. Lancaster GI, O'Connell R, Katz DL, Manson JE, Hutchison WR, Landau C, et al; Healthcare Professionals for Healthcare Reform. The expanding medical and behavioral resources with access to care for everyone health plan. Ann Intern Med. 2009;150:490-2. [PMID: 19258548] LinkGoogle Scholar Author, Article, and Disclosure InformationAffiliations: From University of Washington, Seattle, WA 98104.Disclosures: None disclosed. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoThe Expanding Medical and Behavioral Resources with Access to Care for Everyone Health Plan Gilead I Lancaster , Ryan O'Connell , David L. Katz , JoAnn E. Manson , William R. Hutchison , Charles Landau , Kimberly A. Yonkers , and Comments and Critiques on the EMBRACE Health Care Reform Plan Gary R. Gibson Comments and Critiques on the EMBRACE Health Care Reform Plan Gilead I. Lancaster , Ryan O'Connell , and David L. Katz Comments and Critiques on the EMBRACE Health Care Reform Plan Quentin D. Young Comments and Critiques on the EMBRACE Health Care Reform Plan Richard L. O'Brien and Donald Frey Metrics 3 November 2009Volume 151, Issue 9Page: 671-672KeywordsConflicts of interestHealth care ePublished: 3 November 2009 Issue Published: 3 November 2009 CopyrightCopyright © 2009 by American College of Physicians. All Rights Reserved.PDF DownloadLoading ...